Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
14.60
-0.51 (-3.38%)
At close: Apr 28, 2026, 4:00 PM EDT
14.88
+0.28 (1.92%)
After-hours: Apr 28, 2026, 4:56 PM EDT

Tenax Therapeutics Market Cap

Tenax Therapeutics has a market cap or net worth of $859.62 million as of April 28, 2026. Its market cap has increased by 3,954.82% in one year.

Market Cap
859.62M
Enterprise Value
762.06M
1-Year Change
3,954.82%
Ranking
Category
Stock Price
$14.60

Market Cap Chart

Since January 15, 2010, Tenax Therapeutics's market cap has increased from $148.50M to $859.62M, an increase of 478.87%. That is a compound annual growth rate of 11.38%.

History

DateMarket Cap% Change
Apr 27, 2026259.90M241.52%
Dec 31, 202576.10M260.66%
Dec 31, 202421.10M219.70%
Dec 29, 20236.60M32.00%
Dec 30, 20225.00M-80.92%
Dec 31, 202126.20M11.49%
Dec 31, 202023.50M147.37%
Dec 31, 20199.50M427.78%
Dec 31, 20181.80M-86.96%
Dec 29, 201713.80M-74.82%
Dec 30, 201654.80M-40.63%
Dec 31, 201592.30M-14.54%
Dec 31, 2014108.00M125.94%
Dec 31, 201347.80M123.36%
Dec 31, 201221.40M-45.69%
Dec 30, 201139.40M-10.86%
Dec 31, 201044.20M-70.24%
View and export this data all the way back to 2010. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Phathom Pharmaceuticals 899.94M
LB Pharmaceuticals 899.84M
CytomX Therapeutics 896.90M
Xencor 891.06M
Janux Therapeutics 882.06M
SELLAS Life Sciences Group 876.36M
Theravance Biopharma 863.02M
MannKind 861.54M
Market Cap Rankings